US 12,186,541 B2
Assembly for a drug delivery device comprising a feedback feature
David Aubrey Plumptre, Worcestershire (GB); Naceur Rekaya, Warwickshire (GB); Paul Richard Draper, Worcestershire (GB); Paul Roger Griffin, Worcestershire (GB); and Stephen Francis Gilmore, Bristol (GB)
Assigned to Sanofi-Aventis Deutschland GMBH, Frankfurt am Main (DE)
Filed by Sanofi-Aventis Deutschland GMBH, Frankfurt am Main (DE)
Filed on Apr. 18, 2023, as Appl. No. 18/302,539.
Application 18/302,539 is a continuation of application No. 16/573,918, filed on Sep. 17, 2019, granted, now 11,654,245.
Application 16/573,918 is a continuation of application No. 14/771,178, granted, now 10,471,217, issued on Nov. 12, 2019, previously published as PCT/EP2014/054526, filed on Mar. 10, 2014.
Claims priority of application No. 13159047 (EP), filed on Mar. 13, 2013.
Prior Publication US 2023/0248919 A1, Aug. 10, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/315 (2006.01)
CPC A61M 5/3157 (2013.01) [A61M 5/3155 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An assembly for a drug delivery device, the assembly comprising:
a feedback feature being configured to indicate an end of a dispense operation to a user by giving an audible and/or tactile feedback; and
an actuator configured to be operated to dispense a dose;
wherein the feedback feature creates the audible and/or tactile feedback when the actuator reaches an end position at the end of the dispense operation, and wherein the feedback feature is configured to snap when it is compressed above a certain load to generate the audible and/or tactile feedback.